Trial record 4 of 312 for:    Spasticity

Prevalence of Spasticity in Veterans Living in a Long-term Care Facility

This study is currently recruiting participants.
Verified August 2013 by Vanderbilt University
Merz Pharmaceuticals, LLC
Information provided by (Responsible Party):
David Charles, Vanderbilt University Identifier:
First received: June 12, 2013
Last updated: August 6, 2013
Last verified: August 2013

The purpose of the study is to conduct a feasibility survey of the prevalence of spasticity at a single long-term care facility for veterans and their spouses in Murfreesboro, Tennessee. These data will be used to strengthen a future grant application to the Department of Defense in response to their ongoing Traumatic Brain Injury initiative.


Study Type: Observational
Study Design: Observational Model: Cohort
Time Perspective: Cross-Sectional
Official Title: Prevalence of Spasticity in Veterans Living in a Long-term Care Facility

Further study details as provided by Vanderbilt University:

Primary Outcome Measures:
  • Spasticity diagnosis [ Time Frame: Up to three months after consent is obtained ] [ Designated as safety issue: No ]
    There is no biomarker for spasticity. Therefore, the diagnosis will be made on physician impression. A neurologist trained in movement disorders will examine each consented patient to determine if they have spasticity. The severity of the veteran's spasticity will be documented, including the following measures: presence of fixed contractures and presence of pain on movement.

Secondary Outcome Measures:
  • Spasticity treatment awareness and preferences survey [ Time Frame: Up to three months after consent is obtained ] [ Designated as safety issue: No ]

    The investigators will use a structured interview to assess each subject's level of awareness of available treatments for spasticity. Subjects will be asked if they are aware of specific treatments for spasticity and asked to answer "yes" or "no".

    This interview is also designed to capture subjects' spasticity treatment preferences. Subjects will be asked if they are interested in receiving a variety of available spasticity treatments and asked to answer "yes," "no," or "maybe".

Estimated Enrollment: 140
Study Start Date: February 2013
Estimated Study Completion Date: February 2014
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Detailed Description:

The goal of this feasibility survey is to determine the prevalence of spasticity that interferes with care or function at the Tennessee State Veterans Home (TSVH), which is a long-term care facility for veterans and their spouses in Murfreesboro, Tennessee. In order to accomplish this goal, each of the 140 residents will be examined by the principal investigator and a medical record review will be performed; also, each patient and their medical decision-maker (if applicable), direct caregiver, and treating physician will be surveyed in order to further elucidate the barriers to treatment in this population. All consenting residents of the TSVH will be examined, but the data will be separated prior to analysis based on whether the resident is a veteran or a veteran's relative.


Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Nursing home residents


Inclusion Criteria:

  • Male and female subjects of any race, aged 18 and above.
  • Reside at the Tennessee State Veterans Home

Exclusion Criteria:

  • Subjects for whom it is felt that participation in the study would cause medical harm
  Contacts and Locations
Please refer to this study by its identifier: NCT01879449

Contact: Odessa Lankford 615-343-2961
Contact: Anna Molinari, BA

United States, Tennessee
Tennessee State Veterans Home Recruiting
Murfreesboro, Tennessee, United States, 37130
Contact: Tyler Masden         
Sponsors and Collaborators
Vanderbilt University
Merz Pharmaceuticals, LLC
Principal Investigator: David Charles, M.D. Vanderbilt University
  More Information

No publications provided

Responsible Party: David Charles, Professor and Vice-Chair, Department of Neurology, Vanderbilt University Identifier: NCT01879449     History of Changes
Other Study ID Numbers: 110470VU, VUMC38674-R, VUMC35131-R
Study First Received: June 12, 2013
Last Updated: August 6, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Vanderbilt University:

Additional relevant MeSH terms:
Muscle Spasticity
Muscular Diseases
Musculoskeletal Diseases
Muscle Hypertonia
Neuromuscular Manifestations
Neurologic Manifestations
Nervous System Diseases
Signs and Symptoms processed this record on April 17, 2014